Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials

[1]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[2]  D. Wald,et al.  A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. , 2008, Clinical therapeutics.

[3]  M. Melino,et al.  The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. , 2008, Clinical therapeutics.

[4]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[5]  I. Gavras,et al.  Fixed-drug combinations as first-line treatment for hypertension. , 2006, Progress in cardiovascular diseases.

[6]  Li-sheng Liu,et al.  The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients , 2005, Journal of hypertension.

[7]  Andrew D Oxman,et al.  International variation in prescribing antihypertensive drugs: Its extent and possible explanations , 2005, BMC health services research.

[8]  Hans L. Hillege,et al.  Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria , 2004, Circulation.

[9]  J F Potter,et al.  Extract from : , 2009 .

[10]  J. Grippat,et al.  The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects , 2004, European Journal of Clinical Pharmacology.

[11]  J. Chalmers,et al.  Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting , 2004, European Journal of Clinical Pharmacology.

[12]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[13]  M. Law,et al.  Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. , 2003, Health technology assessment.

[14]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[15]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[16]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[17]  P. Mehler,et al.  Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. , 2002, Kidney international.

[18]  R. Guthrie,et al.  Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension. , 1999, American journal of hypertension.

[19]  J. Massaro,et al.  Antihypertensive profiles with ascending dose combinations of ramipril and felodipine ER. , 1999, Clinical and experimental hypertension.

[20]  H. Black,et al.  Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy , 1998, Journal of Human Hypertension.

[21]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[22]  D. Compagnone,et al.  Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group. , 1998, British journal of clinical pharmacology.

[23]  F. Messerli,et al.  Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. , 1998, American journal of hypertension.

[24]  W. Cushman,et al.  Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension. , 1998, American journal of hypertension.

[25]  J. Chalmers,et al.  Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly , 1997, Journal of hypertension.

[26]  M. Moser,et al.  Low-dose combination therapy in hypertension. , 1997, American family physician.

[27]  B. Tomlinson,et al.  Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension. , 1997, American journal of hypertension.

[28]  W. Cushman,et al.  Use of the factorial design and quadratic response surface models to evaluate the fosinopril and hydrochlorothiazide combination therapy in hypertension. , 1997, American journal of hypertension.

[29]  E. Kuschnir,et al.  Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo. , 1996, Clinical therapeutics.

[30]  S. Snapinn,et al.  Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components. , 1996, Archives of internal medicine.

[31]  A. Kriegman,et al.  Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension. , 1996, Archives of family medicine.

[32]  W. Frishman,et al.  Comparison of Amlodipine and Benazepril Monotherapy to Amlodipine Plus Benazepril In Patients with Systemic Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study , 1995, Journal of clinical pharmacology.

[33]  K. Ferdinand,et al.  Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension. , 1995, American journal of hypertension.

[34]  W. Frishman,et al.  First‐Line Therapy Option with Low‐Dose Bisoprolol Fumarate and Low‐Dose Hydrochlorothiazide in Patients with Stage I and Stage II Systemic Hypertension , 1995, Journal of clinical pharmacology.

[35]  K. Koury,et al.  A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. , 1994, Archives of internal medicine.

[36]  S. Chrysant.  Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. , 1994, Archives of internal medicine.

[37]  Y. Lacourciére,et al.  Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients. , 1994, Journal of human hypertension.

[38]  L. Knapp,et al.  Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group. , 1994, Journal of human hypertension.

[39]  M. Fernández,et al.  Combined Versus Single Effect of Fosinopril and Hydrochlorothiazide in Hypertensive Patients , 1994, Hypertension.

[40]  R. Pordy.  Cilazapril plus hydrochlorothiazide: improved efficacy without reduced safety in mild to moderate hypertension. A double-blind placebo-controlled multicenter study of factorial design. , 1994, Cardiology.

[41]  J. Webster,et al.  An assessment of lacidipine and atenolol in mild to moderate hypertension. , 1994, British journal of clinical pharmacology.

[42]  E. Nelson,et al.  The treatment of mild hypertension study. , 1993, JAMA.

[43]  W. Applegate,et al.  A Randomized, Controlled Trial Comparing Diltiazem, Hydrochlorothiazide, and Their Combination in the Therapy of Essential Hypertension , 1993, Pharmacotherapy.

[44]  F. Messerli,et al.  Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment. , 1993, Clinical therapeutics.

[45]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[46]  V. Cairns,et al.  Short report: Ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design , 1993, Journal of hypertension.

[47]  N. Schneiderman,et al.  Effectiveness of Antihypertensive Medications in Office and Ambulatory Settings: A Placebo‐Controlled Comparison of Atenolol, Metoprolol, Chlorthalidone, Verapamil, and an Atenolol‐Chlorthalidone Combination , 1992, Journal of clinical pharmacology.

[48]  M. Weir,et al.  A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension. , 1992, Journal of human hypertension.

[49]  C. Chappel,et al.  Antihypertensive and Metabolic Effects of Single and Combined Atenolol Regimens , 1992, Journal of clinical pharmacology.

[50]  A. Salvetti,et al.  The Combination of Chlorthalidone with Nifedipine Does Not Exert an Additive Antihypertensive Effect in Essential Hypertensives: A Crossover Multicenter Study , 1991, Journal of cardiovascular pharmacology.

[51]  J. Chalmers,et al.  Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy. , 1990, Journal of hypertension.

[52]  J. McLay,et al.  Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension. , 1990, British journal of clinical pharmacology.

[53]  S. Oparil,et al.  An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy. , 1990, JAMA.

[54]  C. Vermylen,et al.  Bone-marrow Transplantation for Sickle-cell-anemia - Reply , 1988 .

[55]  J. Chalmers,et al.  Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination. , 1988, Clinical and experimental hypertension. Part A, Theory and practice.

[56]  J. Kayanakis,et al.  Comparative study of once-daily administration of captopril 50 mg, hydrochlorothiazide 25 mg and their combination in mild to moderate hypertension. , 1987, British journal of clinical pharmacology.

[57]  D. Clement,et al.  Effect of calcium antagonists on ambulatory blood pressure and its variations. , 1987, Journal of cardiovascular pharmacology.

[58]  J. Chalmers,et al.  Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study. , 1986, Australian and New Zealand journal of medicine.

[59]  J. Cleland,et al.  Combination of verapamil and beta blockers in systemic hypertension. , 1986, The American journal of cardiology.

[60]  J. Cleland,et al.  Cardiovascular responses to verapamil and propranolol in hypertensive patients. , 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[61]  A. J. Dunning,et al.  Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial. , 1984, British medical journal.

[62]  J. Mucklow,et al.  Atenolol and chlorthalidone in combination for hypertension. , 1979, British journal of clinical pharmacology.

[63]  J. Chalmers,et al.  EFFECTS OF TIMOLOL AND HYDROCHLOROTHIAZIDE ON BLOOD-PRESSURE AND PLASMA RENIN ACTIVITY Double-blind Factorial Trial , 1976, The Lancet.

[64]  J. Uther,et al.  A double blind factorial trial of pindolol and hydrochlorothiazide in hypertension , 1976 .